|
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study |
|
|
|
Titel: |
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study |
Auteur: |
Rimini, Margherita Masi, Gianluca Lonardi, Sara Nichetti, Federico Pressiani, Tiziana Lavacchi, Daniele Jessica, Lucchetti Giordano, Guido Scartozzi, Mario Tamburini, Emiliano Pastorino, Alessandro Rapposelli, Ilario Giovanni Daniele, Bruno Martinelli, Erika Garajova, Ingrid Aprile, Giuseppe Schirripa, Marta Formica, Vincenzo Salani, Francesca Winchler, Costanza Bergamo, Francesca Balsano, Rita Gusmaroli, Eleonora Lorenzo, Angotti Landriscina, Matteo Pretta, Andrea Toma, Ilaria Pirrone, Chiara Diana, Anna Leone, Francesco Brunetti, Oronzo Brandi, Giovanni Garattini, Silvio Ken Satolli, Maria Antonietta Rossari, Federico Fornaro, Lorenzo Niger, Monica Zanuso, Valentina De Rosa, Antonio Ratti, Francesca Aldrighetti, Luca De Braud, Filippo Foti, Silvia Rizzato, Mario Domenico Vivaldi, Caterina Stefano, Cascinu Rimassa, Lorenza Antonuzzo, Lorenzo Casadei-Gardini, Andrea |
Verschenen in: |
Targeted oncology |
Paginering: |
Jaargang 19 () nr. 3 pagina's 359-370 |
Jaar: |
2024-05-01 |
Inhoud: |
|
Uitgever: |
Springer International Publishing, Cham |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|